Hu, X., Liu, Y., Wang, B., Tong, Z., Li, H., Zhang, G., Zhang, L., Wu, J., Jin, C., Nie, J., Ding, S., Yi, T., Li, W., Wang, X., Wang, X., Peng, Y., Li, L., Yang, X. (2026). Fovinaciclib versus placebo combined with fulvestrant for advanced breast cancer after endocrine therapy: A randomized, double-blind phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1101